Related Articles
Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy
Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer
Downregulation of LKB1 promotes tumor progression and predicts unfavorable prognosis in patients with glioma
LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin
Downregulation of LKB1 suppresses Stat3 activity to promote the proliferation of esophageal carcinoma cells